BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36069783)

  • 41. Long-term evaluation following resection of apparently benign pheochromocytoma(s)/paraganglioma(s).
    van Heerden JA; Roland CF; Carney JA; Sheps SG; Grant CS
    World J Surg; 1990; 14(3):325-9. PubMed ID: 1973322
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical profiles of patients with surgically resected pheochromocytoma and paraganglioma.
    Lee SH; Park JH; Lee JY; Lee SR; Rhee KS; Chae JK; Kim WH; Sul JY; Oh JK; Kwon HJ; Lee JH; Seong IW
    Korean J Intern Med; 2020 Mar; 35(2):351-359. PubMed ID: 30808127
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular imaging and theranostic approaches in pheochromocytoma and paraganglioma.
    Taïeb D; Pacak K
    Cell Tissue Res; 2018 May; 372(2):393-401. PubMed ID: 29450723
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Management and outcome of metastatic pheochromocytomas/paragangliomas: a monocentric experience.
    De Filpo G; Cantini G; Rastrelli G; Vannini G; Ercolino T; Luconi M; Mannelli M; Maggi M; Canu L
    J Endocrinol Invest; 2022 Jan; 45(1):149-157. PubMed ID: 34227051
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Presentations and management of adrenal hypertension].
    Amar L; Lorthioir A; Giavarini A; Plouin PF; Azizi M
    Presse Med; 2014 Apr; 43(4 Pt 1):420-7. PubMed ID: 24569318
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Left Ventricular Structural and Functional Alterations in Patients With Pheochromocytoma/Paraganglioma Before and After Surgery.
    Dobrowolski P; Januszewicz A; Klisiewicz A; Gosk-Przybyłek M; Pęczkowska M; Kabat M; Kwapiszewska A; Warchoł-Celińska E; Ambroziak U; Doroszko A; Toutounchi S; Gałązka Z; Bednarczuk T; Górnicka B; Januszewicz M; Hoffman P; Lenders JWM; Eisenhofer G; Prejbisz A
    JACC Cardiovasc Imaging; 2020 Dec; 13(12):2498-2509. PubMed ID: 32950457
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Endoscopic treatment of solitary, bilateral, multiple, and recurrent pheochromocytomas and paragangliomas.
    Walz MK; Peitgen K; Neumann HP; Janssen OE; Philipp T; Mann K
    World J Surg; 2002 Aug; 26(8):1005-12. PubMed ID: 12045858
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High specificity of spot urinary free metanephrines in diagnosis and prognosis of pheochromocytomas and paragangliomas by HPLC with electrochemical detection.
    Zuo M; Zhen Q; Zhang X; Zou W; Yang X; Tian G; Shi Z; Li Q; Ding M
    Clin Chim Acta; 2018 Mar; 478():82-89. PubMed ID: 29273559
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Resection of Pheochromocytoma Improves Diabetes Mellitus in the Majority of Patients.
    Beninato T; Kluijfhout WP; Drake FT; Lim J; Kwon JS; Xiong M; Shen WT; Gosnell JE; Liu C; Suh I; Duh QY
    Ann Surg Oncol; 2017 May; 24(5):1208-1213. PubMed ID: 27896511
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risk factors and a predictive nomogram for hemodynamic instability during adrenalectomy for large pheochromocytomas and paragangliomas: A retrospective cohort study.
    Li S; Li Z; Zheng J; Chen X
    Eur J Surg Oncol; 2023 Oct; 49(10):106964. PubMed ID: 37369608
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genetics and imaging of pheochromocytomas and paragangliomas: current update.
    Katabathina VS; Rajebi H; Chen M; Restrepo CS; Salman U; Vikram R; Menias CO; Prasad SR
    Abdom Radiol (NY); 2020 Apr; 45(4):928-944. PubMed ID: 31069476
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pheochromocytoma and Paraganglioma Patients With Poor Survival Often Show Brown Adipose Tissue Activation.
    Abdul Sater Z; Jha A; Hamimi A; Mandl A; Hartley IR; Gubbi S; Patel M; Gonzales M; Taïeb D; Civelek AC; Gharib AM; Auh S; O'Mara AE; Pacak K; Cypess AM
    J Clin Endocrinol Metab; 2020 Apr; 105(4):1176-85. PubMed ID: 31903484
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Plasma methoxytyramine: clinical utility with metanephrines for diagnosis of pheochromocytoma and paraganglioma.
    Rao D; Peitzsch M; Prejbisz A; Hanus K; Fassnacht M; Beuschlein F; Brugger C; Fliedner S; Langton K; Pamporaki C; Gudziol V; Stell A; Januszewicz A; Timmers HJLM; Lenders JWM; Eisenhofer G
    Eur J Endocrinol; 2017 Aug; 177(2):103-113. PubMed ID: 28476870
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [
    Noortman WA; Vriens D; de Geus-Oei LF; Slump CH; Aarntzen EH; van Berkel A; Timmers HJLM; van Velden FHP
    Eur Radiol; 2022 Oct; 32(10):7227-7236. PubMed ID: 36001126
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Determinants of disease-specific survival in patients with and without metastatic pheochromocytoma and paraganglioma.
    Pamporaki C; Prodanov T; Meuter L; Berends AMA; Bechmann N; Constantinescu G; Beuschlein F; Remde H; Januszewicz A; Kerstens MN; Timmers HJLM; Taïeb D; Robledo M; Lenders JWM; Pacak K; Eisenhofer G
    Eur J Cancer; 2022 Jul; 169():32-41. PubMed ID: 35500459
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of Contactin 4 Is Associated With Malignant Behavior in Pheochromocytomas and Paragangliomas.
    Evenepoel L; van Nederveen FH; Oudijk L; Papathomas TG; Restuccia DF; Belt EJT; de Herder WW; Feelders RA; Franssen GJH; Hamoir M; Maiter D; Ghayee HK; Shay JW; Perren A; Timmers HJLM; van Eeden S; Vroonen L; Aydin S; Robledo M; Vikkula M; de Krijger RR; Dinjens WNM; Persu A; Korpershoek E
    J Clin Endocrinol Metab; 2018 Jan; 103(1):46-55. PubMed ID: 28938490
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pheochromocytomas and Hypertension.
    Pappachan JM; Tun NN; Arunagirinathan G; Sodi R; Hanna FWF
    Curr Hypertens Rep; 2018 Jan; 20(1):3. PubMed ID: 29356966
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Correlation between in vivo 18F-FDG PET and immunohistochemical markers of glucose uptake and metabolism in pheochromocytoma and paraganglioma.
    van Berkel A; Rao JU; Kusters B; Demir T; Visser E; Mensenkamp AR; van der Laak JA; Oosterwijk E; Lenders JW; Sweep FC; Wevers RA; Hermus AR; Langenhuijsen JF; Kunst DP; Pacak K; Gotthardt M; Timmers HJ
    J Nucl Med; 2014 Aug; 55(8):1253-9. PubMed ID: 24925884
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Significance of Alpha-inhibin Expression in Pheochromocytomas and Paragangliomas.
    Mete O; Pakbaz S; Lerario AM; Giordano TJ; Asa SL
    Am J Surg Pathol; 2021 Sep; 45(9):1264-1273. PubMed ID: 33826547
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Laparoscopic surgery for pheochromocytoma: adrenalectomy, partial resection, excision of paragangliomas.
    Janetschek G; Finkenstedt G; Gasser R; Waibel UG; Peschel R; Bartsch G; Neumann HP
    J Urol; 1998 Aug; 160(2):330-4. PubMed ID: 9679871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.